Literature DB >> 2460096

Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline.

R M Strieter1, D G Remick, P A Ward, R N Spengler, J P Lynch, J Larrick, S L Kunkel.   

Abstract

Tumor necrosis factor-alpha (TNF), a mononuclear phagocyte (MO)-derived peptide, is increasingly being recognized for its pleomorphic immunologic effects. A number of investigations have demonstrated that lipopolysaccharide (LPS) can induce TNF synthesis, yet mechanisms that regulate TNF expression at the cellular and molecular levels have not been fully elucidated. In this study, we present data demonstrating pentoxifylline, a methylxanthine, is efficacious in suppressing LPS-induced MO-derived TNF at the level of both TNF mRNA accumulation and TNF supernatant bioactivity. Pentoxifylline, at a dose of 1 x 10(-5)M, suppressed the production of both biologically active TNF and TNF mRNA expression by more than 50%. Furthermore, additional methylxanthines and dibutyryl cAMP have similar effects on TNF expression. These data support the mechanism for this suppressive effect is via the generation of intracellular cAMP.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2460096     DOI: 10.1016/s0006-291x(88)81271-3

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  119 in total

1.  Inhibition of human interleukin-12 production by pentoxifylline.

Authors:  D R Moller; M Wysocka; B M Greenlee; X Ma; L Wahl; G Trinchieri; C L Karp
Journal:  Immunology       Date:  1997-06       Impact factor: 7.397

2.  Effect of lisofylline and pentoxifylline on the bacterial-stimulated production of TNF-alpha, IL-1 beta IL-10 by human leucocytes.

Authors:  A M van Furth; E M Verhard-Seijmonsbergen; R van Furth; J A Langermans
Journal:  Immunology       Date:  1997-06       Impact factor: 7.397

3.  Antimicrobial activity of PLUNC protects against Pseudomonas aeruginosa infection.

Authors:  Lina Lukinskiene; Yang Liu; Susan D Reynolds; Chad Steele; Barry R Stripp; George D Leikauf; Jay K Kolls; Y Peter Di
Journal:  J Immunol       Date:  2011-06-01       Impact factor: 5.422

4.  Endomorphin-2 modulates productions of TNF-alpha, IL-1beta, IL-10, and IL-12, and alters functions related to innate immune of macrophages.

Authors:  Yasutaka Azuma; Kiyoshi Ohura
Journal:  Inflammation       Date:  2002-10       Impact factor: 4.092

Review 5.  The pulmonary physician and critical care. 3. Pharmacotherapy in lung injury.

Authors:  M Messent; M J Griffiths
Journal:  Thorax       Date:  1992-08       Impact factor: 9.139

6.  Pentoxifylline in septic shock.

Authors:  P S Sarma
Journal:  Postgrad Med J       Date:  1990-11       Impact factor: 2.401

7.  Liver: Can pentoxifylline secure its place in liver therapeutics?

Authors:  Stuart F W Kendrick; Chris P Day
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-11       Impact factor: 46.802

8.  Pentoxifylline modulation of plasma membrane functions in human polymorphonuclear leukocytes.

Authors:  W L Hand; M L Butera; N L King-Thompson; D L Hand
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

9.  Anticancer and immunostimulatory role of encapsulated tumor antigen containing cobalt oxide nanoparticles.

Authors:  Sourav Chattopadhyay; Sandeep Kumar Dash; Totan Ghosh; Sabyasachi Das; Satyajit Tripathy; Debasis Mandal; Debasis Das; Panchanan Pramanik; Somenath Roy
Journal:  J Biol Inorg Chem       Date:  2013-09-17       Impact factor: 3.358

10.  Pentoxifylline pretreatment fails to block the acute-phase response to Escherichia coli endotoxin in dwarf goats.

Authors:  C T Van Duin; T Wensing; A S Van Miert
Journal:  Vet Res Commun       Date:  1995       Impact factor: 2.459

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.